Whiteville, TN, United States of America

David Dwayne Blurton

This inventor holds 43 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Tissue Retention Devices. Top assignees: Stetrix, Inc., Plexus Biomedical, Inc., Stretrix, Inc.. Active years: 2010-2026.

USPTO Granted Patents = 43 

% Patents Active = 100.0


 

Average Co-Inventor Count = 1.8

ph-index = 8

Forward Citations = 204(Granted Patents)


Company Filing History:


Years Active: 2010-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Tissue Retention
Perianal Support
Labor Management
Intrapartum Support
Hemorrhoids Prevention
Adipose Tissue Retention
Pelvic Floor Support
Sweat Absorption
Abdominal Aeration
Cesarean Childbirth
Flexible Supports
Labor Monitoring
43 patents (USPTO):Explore Patents

Title: The Innovative Journey of David Dwayne Blurton

Introduction: David Dwayne Blurton, a talented inventor hailing from Whiteville, TN (US), has made significant contributions to the world of innovation with his creative mind and dedication to problem-solving.

Latest Patents: David Dwayne Blurton's latest patents include groundbreaking inventions in the field of renewable energy technology, with a focus on solar power optimization and energy storage solutions.

Career Highlights: Throughout his career, David Dwayne Blurton has been recognized for his pioneering work in sustainable technologies, earning multiple awards for his innovative approach to environmental challenges.

Collaborations: David Dwayne Blurton has collaborated with leading research institutions and universities to further develop his inventions, showcasing his ability to work effectively in multidisciplinary teams.

Conclusion: In conclusion, David Dwayne Blurton stands as a shining example of an inventor who is committed to creating a more sustainable future through his groundbreaking innovations and unwavering passion for technological advancement.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…